Tamil Nadu’s first Economic Survey 2024-25 has indicated that the State is expected to maintain a growth rate of above 8% in ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...